Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Receivables (2019 - 2025)

IM Cannabis has reported Receivables over the past 7 years, most recently at $7.9 million for Q4 2025.

  • Quarterly results put Receivables at $7.9 million for Q4 2025, down 21.29% from a year ago — trailing twelve months through Dec 2025 was $7.9 million (down 21.29% YoY), and the annual figure for FY2025 was $7.9 million, down 23.01%.
  • Receivables for Q4 2025 was $7.9 million at IM Cannabis, down from $10.1 million in the prior quarter.
  • Over the last five years, Receivables for IMCC hit a ceiling of $14.7 million in Q4 2021 and a floor of $979497.6 in Q2 2024.
  • Median Receivables over the past 5 years was $7.2 million (2025), compared with a mean of $7.8 million.
  • Biggest five-year swings in Receivables: soared 2539.44% in 2021 and later tumbled 55.44% in 2022.
  • IM Cannabis' Receivables stood at $14.7 million in 2021, then tumbled by 55.44% to $6.5 million in 2022, then dropped by 3.52% to $6.3 million in 2023, then surged by 59.69% to $10.1 million in 2024, then decreased by 21.29% to $7.9 million in 2025.
  • The last three reported values for Receivables were $7.9 million (Q4 2025), $10.1 million (Q4 2024), and $979497.6 (Q2 2024) per Business Quant data.